XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders' Equity of WSFS
Common Stock
Capital in Excess of Par Value
Accumulated Other Comprehensive Loss
Retained Earnings
Treasury Stock
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2022     75,921,997          
Beginning balance at Dec. 31, 2022 $ 2,201,886 $ 2,205,113 $ 759 $ 1,974,210 $ (675,844) $ 1,411,243 $ (505,255) $ (3,227)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 62,662 62,404       62,404   258
Other comprehensive (loss) income 57,429 57,429     57,429      
Cash dividend (9,255) (9,255)       (9,255)    
Distributions to noncontrolling shareholders (49)             (49)
Issuance of common stock including proceeds from exercise of common stock options (in shares)     36,603          
Issuance of common stock including proceeds from exercise of common stock options 362 362   362        
Stock-based compensation expense 3,185 3,185   3,185        
Repurchases of common stock [1] (12,876) (12,876)         (12,876)  
Ending balance (in shares) at Mar. 31, 2023     75,958,600          
Ending balance at Mar. 31, 2023 2,303,344 2,306,362 $ 759 1,977,757 (618,415) 1,464,392 (518,131) (3,018)
Beginning balance (in shares) at Dec. 31, 2023     76,095,094          
Beginning balance at Dec. 31, 2023 2,469,815 2,477,636 $ 761 1,984,746 (593,991) 1,643,657 (557,537) (7,821)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 65,723 65,761       65,761   (38)
Other comprehensive (loss) income (42,916) (42,916)     (42,916)      
Cash dividend (9,069) (9,069)       (9,069)    
Issuance of common stock including proceeds from exercise of common stock options (in shares)     38,502          
Issuance of common stock including proceeds from exercise of common stock options 599 599   599        
Stock-based compensation expense 2,455 2,455   2,455        
Repurchases of common stock [2] (20,985) (20,985)         (20,985)  
Ending balance (in shares) at Mar. 31, 2024     76,133,596          
Ending balance at Mar. 31, 2024 $ 2,465,622 $ 2,473,481 $ 761 $ 1,987,800 $ (636,907) $ 1,700,349 $ (578,522) $ (7,859)
[1] Repurchase of common stock includes 262,000 shares repurchased in connection with the Company's share repurchase program approved by the Board of Directors, and 8,258 shares withheld to cover tax liabilities.
[2] Repurchase of common stock includes 492,368 shares repurchased in connection with the Company's share repurchase program approved by the Board of Directors.